Peking University Cancer Hospital & Institute: Neoplasms trials

The registry lists 17 Neoplasms studies with Peking University Cancer Hospital & Institute as lead sponsor. 8 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 1 4Phase 2 3No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• 18F-grazy-02 PET/CT of Granzyme B Expression for Monitoring ImmunotherapyRecruitingNCT07724535Phase 1/2
• Iparomlimab/Tuvonralimab Combined With Bevacizumab and CAPEOX as Conversion Therapy for Colorectal Cancer Liver MetastasisNot yet recruitingNCT07007728Phase 2
• TF-antigen Targeting Molecular Probe for PET Imaging in Solid TumorsNot yet recruitingNCT06755086
• A Clinical Research About CD70-targeted CAR-NKT Cells Therapy in Subjects with Advanced Malignant Solid TumorsRecruitingNCT06728189Phase 1
• CD147 Targeting Peptide Probe for PET Imaging in Solid TumorsNot yet recruitingNCT06720298
• Registry Study in MSI/dMMR Solid TumorsRecruitingNCT06004713
• Evaluate the Safety and Tolerability of JCXH-212 Monotherapy and Combined With Toripalimab in the Treatment of Malignant Solid TumorsRecruitingNCT05579275Early Phase 1
• Nectin-4 Targeting ADC Probe for PET Imaging in Solid TumorsNot yet recruitingNCT05322512Not applicable
• Construction and Clinical Translation of ACE Targeted Nuclear Medicine Imaging ProbeCompletedNCT06203119Phase 1
• Preliminary Study on Eye Features of Patients With Malignant TumorsCompletedNCT04224298
• A Trial on Contrast-enhanced Ultrasound Versus Conventional Ultrasound Guided Biopsy of Liver NeoplasmsStatus unknownNCT02413437Not applicable
• Safety Study of Combining Ultrasound Microbubbles and Chemotherapy to Treat Malignant Neoplasms of Digestive SystemStatus unknownNCT02233205Phase 1/2
• Study of Chemotherapy With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer PatientsCompletedNCT01395056
• Gene Expression Profiling of Breast Cancer Cells Predict the Response of Malignant Pleural EffusionCompletedNCT01256801
• Study of High-dose Chemotherapy (HDC) Combined With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer PatientsCompletedNCT01232062
• Study the Role of Stem Cell in Curing Drug Induced Liver Injury in Metastatic Breast Cancer (MBC)CompletedNCT01231022
• Gene Expression Profiling of Metastatic Breast Cancer Predict the Therapeutic Response to ChemotherapyCompletedNCT01198301